Citations

Showing 10 of 108152 citations.

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma
Wang, Yucai , Link, Brian K. , Witzig, Thomas E. , Maurer, Matthew J. , Allmer, Cristine, King, Rebecca L. , Feldman, Andrew L. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Witzig, T.E. , Feldman, Andrew L , Maurer, Matthew , Link, Brian K , Wang, Yucai , Habermann, Thomas M. , Slager, Susan L. , Cerhan, James R.

Mayo Clinic

Blood | July 26, 2019 | Volume: 134 | Issue: 16 | Pages: 1289-1297

10.1182/blood.2019000858 | PMID 31350266 Get It

Abstract In this month's CME article, an analysis of over 1300 patients with diffuse large B-cell lymphoma (DLBCL), Wang et al demonstrate that the approximately 13% of patients with concurrent indolent lymphoma at diagnosis had the same prognosis as those patients with isolated DLBCL.
Treatment and long-term outcomes in pituitary carcinoma: a cohort study
Santos-Pinheiro, Fernando , Penas‐Prado, Marta, Kamiya-Matsuoka, Carlos, Mahajan, Anita , Brown, Paul D. , Shah, Komal , McCutcheon, Ian E. , Peñas-Prado, Marta , Waguespack, Steven G. , Fuller, Gregory N.

Mayo Clinic

European Journal of Endocrinology | July 26, 2019 | Volume: 181 | Issue: 4 | Pages: 397-407

10.1530/eje-18-0795 | PMID 31349217 Get It

Background Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed when a pituitary adenoma (PA) becomes metastatic. PCs are typically resistant to therapy and develop multiple recurrences despite surgery, radiotherapy and chemotherapy. Recently, treatment with temozolomide (TMZ) has shown promising results, although the lack of prospective trials limits assessment of benefit. Methods We describe a single-center multidisciplinary experience in managing PC patients over a 22-year period and review previously published PC series. Results Seventeen patients were identified. Median age at PC diagnosis was 44 years (range 16–82 years), and the median time from PA to PC transformation was 5 years (range 1–29 years). Median follow-up time was 28 months. Most PCs were hormone-positive (n = 12): ACTH (n = 5), PRL (n = 4), LH/FSH (n = 2) and GH (n = 1). All patients underwent at least one resection and at least one course of radiation after PC diagnosis. Immunohistochemistry showed high Ki-67 labeling index (>3%) in 10/15 cases. Eight patients (47%) had only central nervous system (CNS) metastases; six (35%) had combined CNS and systemic metastases. The most commonly used chemotherapy was TMZ, and TMZ-based therapy was associated with the longest PFS in 12 (71%) cases, as well as the longest period from PC diagnosis to first progression (median 30 months). The 2, 3 and 5-year survival rate of the entire cohort was 71, 59 and 35%, respectively. All patients surviving >5 years had been treated with TMZ-based therapy. Conclusions PC management benefits from multidisciplinary care and multimodality therapy. TMZ-based regimens were associated with high survival rates and long disease control.
Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease
Reddy, Yogesh N.V. , Rodeheffer, Richard J. , Bailey, Kent R. , Jenkins, Gregory D. , Batzler, Anthony , Redfield, Margaret M. , Burnett, John C. , Pereira, Naveen L. , Iyer, Seethalakshmi R., Jenkins, Gregory, Nishimura, Rick , Iyer, Seethalakshmi , Scott, Christopher G. , Bailey, Kent R

Mayo Clinic

Journal of the American Heart Association | July 26, 2019 | Volume: 8 | Issue: 15 | Pages: No page available

10.1161/jaha.119.012943 | PMID 31345101 Get It

Background Neprilysin is a metalloprotease involved in proteolysis of numerous peptides, including natriuretic peptides, and is of prognostic and therapeutic importance in heart failure with reduced ejection fraction. No studies have investigated circulating neprilysin in the community, its clinical correlates, or its relationship to cardiovascular disease in the general population. Methods and Results Plasma neprilysin was measured in 1536 participants from Olmsted County, Minnesota, using a commercially available sandwich ELISA assay. Clinical and echocardiographic correlates and subsequent outcomes were determined. Soluble neprilysin is non‐normally distributed in the community (median: 3.9 ng/mL; interquartile range: 1.0–43.0 ng/mL). There was no relationship between plasma neprilysin and age (Spearman correlation: −0.04, P =0.16); body mass index (Spearman correlation: −0.04, P =0.16); glomerular filtration rate (Spearman correlation: −0.007, P =0.8); or A‐, B‐, or C‐type natriuretic peptides (Spearman correlation: 0.03, P =0.22; −0.001, P =0.96; 0.01, P =0.67, respectively). Among tertiles of neprilysin, the lowest tertile group had the highest prevalence of smokers ( P <0.001), hypertension ( P =0.04), dyslipidemia ( P =0.03), and diastolic dysfunction ( P =0.02). Soluble neprilysin was not prospectively associated with death or heart failure over a median of 10.7 years. Conclusions In a large community‐based cohort, for the first time, we described the distribution of circulating neprilysin in the general community. We observed that neprilysin does not correlate with natriuretic peptide levels and is not independently associated with adverse outcomes. The novel associations observed between low soluble neprilysin levels and an adverse cardiometabolic and smoking profile requires further investigation.
Effect of Heart Rate Variability on the Association Between the Apnea-Hypopnea Index and Cerebral Small Vessel Disease
Brutto, Óscar H. Del , Mera, Robertino M. , Costa, Aldo F. , Castillo, Pablo R. , Castillo, Pablo R

Mayo Clinic

Stroke | July 26, 2019 | Volume: 50 | Issue: 9 | Pages: 2486-2491

10.1161/strokeaha.119.026095 | PMID 31345136 Get It

Background and Purpose— The apnea-hypopnea index (AHI) is associated with cerebral small vessel disease (cSVD), but pathogenesis of this association is elusive. We aimed to assess the effect of nighttime heart rate variability (HRV)—as a proxy of sympathetic upregulation—on the aforementioned association. Methods— Atahualpa residents aged ≥60 years undergoing brain magnetic resonance imaging, polysomnography, and 24-hour Holter monitoring (N=176) were included. The presence of moderate-to-severe white matter hyperintensities, deep cerebral microbleeds, lacunar infarcts, and >10 enlarged basal ganglia perivascular spaces were added for estimating the cSVD score. Interaction models were fitted to assess the effect modification of nighttime HRV in the association between the AHI and the cSVD score, and mediation analysis was utilized to assess the proportion of total effect by nighttime HRV on this association. Results— Generalized linear models showed a significant association between the AHI and the cSVD score ( P =0.025), as well as a significant inverse association between nighttime HRV and the cSVD score ( P =0.002), but no association between daytime HRV and the cSVD score ( P =0.097). Interaction models showed a significant interaction of nighttime HRV on the association between AHI and the cSVD score ( P =0.001), and mediation analysis found that the percent of total effect between AHI and cSVD score mediated by HRV was 30.8%. Predictive marginal means of the cSVD score were highly significant when the 10th percentile of nighttime HRV was compared across categories of 10th and 90th percentiles of the AHI (cSVD score margins, 0.61 [95% CI, 0.37–0.86] versus 1.67 [95% CI, 1.26–2.09]). Contour plots showed the effect of nighttime (but not daytime) HRV on the association between AHI and the cSVD score. Conclusions— This study shows an important effect of nighttime HRV on the association between the AHI and the cSVD score and provides further support for the role of sympathetic overactivity on this association.
Bilateral Kienböck’s disease in a child with Factor V Leiden thrombophilia: a case report
Huang, Tony Chieh‐Ting , Li, Jialun , Moran, Steven L.

Mayo Clinic

Journal of Hand Surgery (European Volume) | July 26, 2019 | Volume: 44 | Issue: 8 | Pages: 859-861

10.1177/1753193419864815 | PMID 31345086 Get It

New-Onset Resistant Hypertension in a Newly Diagnosed Prostate Cancer Patient
Klomjit, Nattawat , Rowan, Daniel J. , Kattah, Andrea G. , Taler, Sandra J. , Bancos, Irina , Klomjit, Nattawat

Mayo Clinic

American Journal of Hypertension | July 26, 2019 | Volume: 32 | Issue: 12 | Pages: 1214-1217

10.1093/ajh/hpz125 | PMID 31353410 Get It

Abstract BACKGROUND New onset resistant hypertension in a previously stable patient with chronic hypertension should lead to consideration of secondary causes. Electrolyte abnormalities are useful clues for identifying some common causes, especially mineralocorticoid excess. CASE PRESENTATION We report the case of a 69-year-old man who developed severe resistant hypertension despite the use of 6 antihypertensive medications, including diuretics. He had metabolic alkalosis and hypokalemia with suppressed plasma renin activity and serum aldosterone. Concurrently, he was diagnosed with small cell neuroendocrine carcinoma of the prostate gland, a rare form of prostate cancer. Despite absence of typical Cushingoid features, investigation confirmed the diagnosis of ectopic adrenocorticotropic hormone (ACTH) syndrome from neuroendocrine prostate cancer. Because of the severity of his hypercortisolism, he underwent urgent bilateral adrenalectomy for hormonal and symptomatic control. Blood pressure improved significantly and he was dismissed with a single antihypertensive agent. Unfortunately, the patient died from his cancer 1 month later. CONCLUSION Primary and secondary hyperaldosteronism are usually diagnosed based on measurements of aldosterone and plasma renin activity. However, if plasma renin activity and aldosterone are both low, rare causes of mineralocorticoid excess such as ectopic ACTH syndrome should be entertained.
In Response
Dahan, Albert , Brull, Sorin J. , Bíró, Péter , Brull, Sorin J

Mayo Clinic

Anesthesia & Analgesia | July 26, 2019 | Volume: 129 | Issue: 4 | Pages: e139-e140

10.1213/ane.0000000000004333 | PMID 31348057 Get It

Awake Volunteer Pain Scores During Neuromuscular Monitoring
Nemes, Réka, Nagy, György M., Murphy, Glenn S. , Logvinov, Ilana I. , Nagy, György, Fülesdi, Béla , Renew, J. Ross , Logvinov, Ilana

Mayo Clinic

Anesthesia & Analgesia | July 26, 2019 | Volume: 130 | Issue: 4 | Pages: 941-948

10.1213/ane.0000000000004326 | PMID 31348055 Get It

BACKGROUND: There is a need for easy to use, reliable neuromuscular monitors (NMMs). This multicenter, prospective, unblinded study compared the discomfort associated with neurostimulation in unmedicated healthy volunteers when using the new electromyography (EMG)-based TetraGraph and acceleromyography (AMG)-based TOF-Watch NMMs. The secondary aim was to compare the repeatability of the train-of-four (TOF) ratios (TOFRs) obtained with the 2 devices. METHODS: The TOF measurements of 135 volunteers from 3 university hospitals were analyzed (age: 38.3 ± 12 years [mean ± standard deviation [SD]]; male/female ratio = 63:72). The left or right ulnar nerve was stimulated at the wrist in TOF mode with 20, 30, 40, and 50 mA stimulating current intensities with both devices in random order. The TOF-Watch used standard electrocardiography (ECG) electrodes (Red Dot; 3M Health Care) for nerve stimulation. The stimulating surface area of 1 ECG electrode is 113 mm 2 . The piezoelectric probe was attached to the thumb, and a hand adapter was used to ensure consistency of AMG measurements. The TetraGraph uses proprietary surface strip electrodes for nerve stimulation and muscle action potential recording, whose stimulating surface area is roughly twice as big as that of standard ECG electrodes (228.5 mm 2 ). The volunteers were asked to rate the discomfort associated with neurostimulation on a 0–10 verbal numerical rating scale (VNRS) score anchored with 0 (no pain) and 10 (worst pain ever experienced). A linear mixed-effects model was used to evaluate the difference in VNRS scores between devices. P <.05 was accepted as the level of significance. RESULTS: In the linear mixed-effects model, there were no differences in VNRS scores between devices at any of the stimulating current intensities, P = .38. The median (range) VNRS scores obtained with TOF-Watch and TetraGraph devices were 2 (0–7) vs 2 (0–8) at 20 mA, 3 (1–9) vs 3 (1–9) at 30 mA, 5 (1–10) vs 5 (1–10) at 40 mA, and 5 (1–10) vs 6 (1–10) at 50 mA stimulating current intensities. The mean of the 1469 TOFRs obtained with TetraGraph was 100.43% ± 7.74% (standard error = 0.2%). Due to technical difficulties, the repeatability of the TOFRs could not be determined. CONCLUSIONS: Despite the different size and design of the stimulating electrodes, the 2 NMMs caused the same level of discomfort in unmedicated healthy volunteers.